Sud A - Search Results

1

An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions.

Chiu K, Pandya S, Sharma M, Hooimeyer A, de Souza A, Sud A. Chiu K, et al. Among authors: sud a. Health Policy. 2024 Mar;141:104993. doi: 10.1016/j.healthpol.2024.104993. Epub 2024 Jan 12. Health Policy. 2024. PMID: 38237202 Free article. Review.

2

Education as drug policy: A realist synthesis of continuing professional development for opioid agonist therapy.

Sachidanandan G, Bechard LE, Hodgson K, Sud A. Sachidanandan G, et al. Among authors: sud a. Int J Drug Policy. 2022 Oct;108:103807. doi: 10.1016/j.drugpo.2022.103807. Epub 2022 Aug 2. Int J Drug Policy. 2022. PMID: 35930903 Free article. Review.

3

The Impact of Suboxone's Market Exclusivity on Cost of Opioid Use Disorder Treatment.

McGee M, Chiu K, Moineddin R, Sud A. McGee M, et al. Among authors: sud a. Appl Health Econ Health Policy. 2023 May;21(3):501-510. doi: 10.1007/s40258-022-00787-0. Epub 2023 Jan 18. Appl Health Econ Health Policy. 2023. PMID: 36652186 Free PMC article.

4

How policy problems and solutions travel in the scientific literature: An international scientometric analysis of the French Model of opioid use disorder care.

Kankanam Gamage K, Chiu K, Ryk J, Grundy Q, Sud A. Kankanam Gamage K, et al. Among authors: sud a. J Eval Clin Pract. 2023 Jun;29(4):576-590. doi: 10.1111/jep.13822. Epub 2023 Mar 7. J Eval Clin Pract. 2023. PMID: 36880987

5

Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States.

Sud A, Chiu K, Friedman J, Dupouy J. Sud A, et al. Int J Drug Policy. 2023 Oct;120:104161. doi: 10.1016/j.drugpo.2023.104161. Epub 2023 Aug 22. Int J Drug Policy. 2023. PMID: 37619440 Free article.

6

Methadone Prescribing Regulation for Opioid Use Disorder in Canada: Evidence for an East-West Policy Divide.

Campbell C, Chiu K, Sud A. Campbell C, et al. Among authors: sud a. Healthc Policy. 2024 Feb;19(3):49-61. doi: 10.12927/hcpol.2024.27228. Healthc Policy. 2024. PMID: 38721734 Free PMC article.

7

Federal opioid agonist therapy policy: interrupted time series analysis of the impact of the methadone exemption removal across eight provinces in Canada.

Sud A, Campbell C, Sivakumar A, Upshur R, Moineddin R, Chiu K. Sud A, et al. BMC Health Serv Res. 2024 Aug 5;24(1):893. doi: 10.1186/s12913-024-11281-9. BMC Health Serv Res. 2024. PMID: 39103784 Free PMC article.

8

Reframing conceptualizations of primary care involvement in opioid use disorder treatment.

Chiu K, Sud A. Chiu K, et al. Among authors: sud a. BMC Prim Care. 2024 Sep 30;25(1):356. doi: 10.1186/s12875-024-02607-x. BMC Prim Care. 2024. PMID: 39350088 Free PMC article.

9

Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions.

Salamanca-Buentello F, Cheng DK, Sabioni P, Majid U, Upshur R, Sud A. Salamanca-Buentello F, et al. Among authors: sud a. Int J Drug Policy. 2022 Mar;101:103556. doi: 10.1016/j.drugpo.2021.103556. Epub 2021 Dec 11. Int J Drug Policy. 2022. PMID: 34902805 Free article. Review.

10

Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada.

Sud A, McGee M, Mintzes B, Herder M. Sud A, et al. Int J Drug Policy. 2022 Jul;105:103749. doi: 10.1016/j.drugpo.2022.103749. Epub 2022 May 26. Int J Drug Policy. 2022. PMID: 35643048 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters